| CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis T Fukumori, Y Takenaka, T Yoshii, HRC Kim, V Hogan, H Inohara, ... Cancer research 63 (23), 8302-8311, 2003 | 495 | 2003 |
| Galectin-3 and metastasis Y Takenaka, T Fukumori, A Raz Glycoconjugate journal 19, 543-549, 2002 | 445 | 2002 |
| Galectin-3, a novel binding partner of β-catenin T Shimura, Y Takenaka, S Tsutsumi, V Hogan, A Kikuchi, A Raz Cancer research 64 (18), 6363-6367, 2004 | 307 | 2004 |
| Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs Y Takenaka, T Fukumori, T Yoshii, N Oka, H Inohara, HRC Kim, ... Molecular and cellular biology 24 (10), 4395-4406, 2004 | 280 | 2004 |
| Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma Y Honjo, H Inohara, S Akahani, T Yoshii, Y Takenaka, J Yoshida, K Hattori, ... Clinical Cancer Research 6 (12), 4635-4640, 2000 | 227 | 2000 |
| Implication of galectin-3 in Wnt signaling T Shimura, Y Takenaka, T Fukumori, S Tsutsumi, K Okada, V Hogan, ... Cancer research 65 (9), 3535-3537, 2005 | 197 | 2005 |
| Galectin-3 inhibits tumor necrosis factor–related apoptosis-inducing ligand–induced apoptosis by activating Akt in human bladder carcinoma cells N Oka, S Nakahara, Y Takenaka, T Fukumori, V Hogan, H Kanayama, ... Cancer research 65 (17), 7546-7553, 2005 | 179 | 2005 |
| Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells T Yoshii, H Inohara, Y Takenaka, Y Honjo, S Akahani, T Nomura, A Raz, ... International journal of oncology 18 (4), 787-792, 2001 | 173 | 2001 |
| Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways T Fukumori, Y Takenaka, N Oka, T Yoshii, V Hogan, H Inohara, ... Cancer research 64 (10), 3376-3379, 2004 | 165 | 2004 |
| Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer T Fukumori, N Oka, Y Takenaka, P Nangia-Makker, E Elsamman, T Kasai, ... Cancer research 66 (6), 3114-3119, 2006 | 164 | 2006 |
| Malignant transformation of thyroid follicular cells by galectin-3 Y Takenaka, H Inohara, T Yoshii, K Oshima, S Nakahara, S Akahani, ... Cancer letters 195 (1), 111-119, 2003 | 145 | 2003 |
| Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population H Maruyama, T Yasui, T Ishikawa‐Fujiwara, E Morii, Y Yamamoto, ... Cancer science 105 (4), 409-417, 2014 | 124 | 2014 |
| L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo … T TSUjIMOTO, Y Yamamoto, M Wasa, Y TAkENAkA, S NAkAHARA, ... Oncology reports 33 (1), 33-39, 2015 | 122 | 2015 |
| CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma T Fukusumi, H Ishii, M Konno, T Yasui, S Nakahara, Y Takenaka, ... British journal of cancer 111 (3), 506-514, 2014 | 113 | 2014 |
| Prognostic role of neutrophil‐to‐lymphocyte ratio in head and neck cancer: a meta‐analysis Y Takenaka, R Oya, T Kitamiura, N Ashida, K Shimizu, K Takemura, ... Head & neck 40 (3), 647-655, 2018 | 110 | 2018 |
| Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin T Yasui, E Morii, Y Yamamoto, T Yoshii, Y Takenaka, S Nakahara, T Todo, ... PLoS One 9 (4), e95364, 2014 | 104 | 2014 |
| Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: a meta‐analysis Y Takenaka, H Cho, S Nakahara, Y Yamamoto, T Yasui, H Inohara Head & neck 37 (7), 1073-1080, 2015 | 94 | 2015 |
| Platelet count and platelet‐lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta‐analysis Y Takenaka, R Oya, T Kitamiura, N Ashida, K Shimizu, K Takemura, ... Head & neck 40 (12), 2714-2723, 2018 | 82 | 2018 |
| Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis Y Takenaka, R Oya, N Takemoto, H Inohara Journal of cachexia, sarcopenia and muscle 12 (5), 1122-1135, 2021 | 60 | 2021 |
| Prognostic significance of body mass index before treatment for head and neck cancer Y Takenaka, N Takemoto, S Nakahara, Y Yamamoto, T Yasui, ... Head & neck 37 (10), 1518-1523, 2015 | 57 | 2015 |
